Attention deficit and hyperactivity disorder: a therapeutic option
To evaluate the use of a therapeutic regimen to treat attention deficit hyperactivity disorder patients.
A total of 140 patients initially underwent physical, neurological and laboratory evaluation. Thereafter, treatment was initiated with a compounding product consisting of a tricyclic antidepressant and an anxiolytic.
The response was positive in 71.43% of patients in controlling hyperactivity and improving dispersion and attention deficit.
The therapeutic regimen utilized proved to be an effective therapeutic alternative, especially for patients who do not adapt to psychostimulant drugs.